Projects per year
Fingerprint
Dive into the research topics where Amarnath Natarajan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
Natarajan, A. (PI)
Project: Research project
-
HTS to Identify Small Molecule Inhibitors of Phospho-Specific Protein-Protein Int
Natarajan, A. (PI)
Project: Research project
-
Targeting Endometrial Cancer with Novel Small Molecule Modulators of PP2A
Buckley-McKeown, S. M. (CoPI), Ghosal, G. (CoPI), Kelly, D. L. (CoPI), Woods, N. T. (CoPI), Black, A. R. (CoPI), Lewis, R. E. (PI), Fisher, K. W. (CoPI), Natarajan, A. (CoPI), Alvarez, S. (CoPI) & Hewitt, K. J. (CoPI)
Project: Research project
-
-
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
Natarajan, A. (PI)
Project: Research project
-
The role of Tyr34 in proton coupled electron transfer and product inhibition of manganese superoxide dismutase
Azadmanesh, J., Slobodnik, K., Struble, L. R., Lovelace, J. J., Cone, E. A., Dasgupta, M., Lutz, W. E., Kumar, S., Natarajan, A., Coates, L., Weiss, K. L., Myles, D. A. A., Kroll, T. & Borgstahl, G. E. O., Dec 2025, In: Nature communications. 16, 1, 1887.Research output: Contribution to journal › Article › peer-review
Open Access -
GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior
Bhat, A. M., Mohapatra, B. C., Luan, H., Mushtaq, I., Chakraborty, S., Kumar, S., Wu, W., Nolan, B., Dutta, S., Storck, M. D., Schott, M., Meza, J. L., Lele, S. M., Lin, M. F., Cook, L. M., Corey, E., Morrissey, C., Coulter, D. W., Rowley, M. J. & Natarajan, A. & 3 others, , Dec 2024, In: Scientific reports. 14, 1, 13523.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Immunogenic Cell Death Traits Emitted from Chronic Lymphocytic Leukemia Cells Following Treatment with a Novel Anti-Cancer Agent, SpiD3
Schmitz, E., Ridout, A., Smith, A. L., Eiken, A. P., Skupa, S. A., Drengler, E. M., Singh, S., Rana, S., Natarajan, A. & El-Gamal, D., Dec 2024, In: Biomedicines. 12, 12, 2857.Research output: Contribution to journal › Article › peer-review
Open Access -
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
Eiken, A. P., Smith, A. L., Skupa, S. A., Schmitz, E., Rana, S., Singh, S., Kumar, S., Mallareddy, J. R., de Cubas, A. A., Krishna, A., Kalluchi, A., Rowley, M. J., D’Angelo, C. R., Lunning, M. A., Bociek, R. G., Vose, J. M., Natarajan, A. & El-Gamal, D., May 1 2024, In: Cancer Research Communications. 4, 5, p. 1328-1343 16 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives
Vorderbruggen, M., Velázquez-Martínez, C. A., Natarajan, A. & Karpf, A. R., May 2024, In: International journal of molecular sciences. 25, 10, 5067.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations